Примери за използване на B-cell на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Diffuse large B-cell lymphoma(DLBCL);
B-cell depletion in utero was detected.
Primary mediastinal large B-cell lymphoma(PMBCL).
Large B-cell lymphoma of the gastric antrum.
Antigen processing and presentation,T- and B-cell function;
B-cell defects account for 50% of primary immunodeficiency.
Ibrutinib was developed for additional B-cell malignancies including….
The capacity of B-cell reconstitution and preexisting humoral immunity are preserved.
A fatal case of Epstein-Barr virus(EBV)positive B-cell lymphoma has also been observed.
B-cell aplasia leading to hypogammaglobulinaemia can occur in patients receiving treatment with YESCARTA.
The extent and duration of B-cell depletion was consistent in the PPMS and RMS trials.
Live vaccines should not be administered during treatment and thereafter until B-cell recovery.
It is more like diffuse large B-cell lymphoma than other types of follicular lymphoma.
Key words: gestational diabetes mellitus, insulin resistance,insulin sensitivity, b-cell dysfunction.
Overall, 48% of patients had activated B-cell(ABC) DLBCL and 40% had germinal center B-cell like(GCB) DLBCL.
Pharmacokinetics of ibrutinib does not significantly differ in patients with different B-cell malignancies.
I was diagnosed with low-grade B-cell lymphoma(MALT type) in 2003 through a tumor in the lacrimal gland of my left eye.
Treatment of rituximab relapsed orrefractory CD20+ follicular B-cell non-Hodgkin's lymphoma(NHL).
B-cell counts returned to normal levels in the offspring, and immunologic function was restored within 6 months of birth.
In all patients with CLL,ofatumumab induces rapid and profound B-cell depletion, whether given as a single agent or in combination.
B-cell acute lymphoblastic leukaemia(B-cell ALL)- a form of cancer that affects some other types of white blood cells.
Summary of Efficacy Data in patients with relapsed/refractory low-grade or follicular non-Hodgkin's lymphoma(NHL),or transformed B-cell NHL.
The initiation of B-cell recovery was first noted at Month 9, when 56% of patients had detectable B-cells.
Sixty-six patients were evaluable for cell-of-origin classifications(germinal center B-cell type[GCB] or activated B-cell type[ABC]).
MabCampath is indicated for the treatment of patients with B-cell chronic lymphocytic leukaemia(B- CLL) for whom fludarabine combination chemotherapy is not appropriate.
The section 4.8 of the SmPC regarding lymphomas specifies that cases of lymphoma include also a fatal case of Epstein-Barr virus(EBV)positive B-cell lymphoma.
In pure B-cell disorders, cellular immunity generally is intact and the frequency of viral, fungal, and mycobacterial(e.g. tuberculosis) infections is not increased.
Consideration should be given to the need for regular monitoring of blood cell count andfor increased risk of infections while patients are B-cell depleted.
MabCampath is used for the treatment of B-cell chronic lymphocytic leukaemia(B-CLL) in cases where fludarabine combination chemotherapy is not appropriate for you.
A total of 108 patients were treated with YESCARTA in a phase 1/2 open-label, multicentre, singlearm study in patients with relapsed orrefractory aggressive B-cell NHL.